Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
30.33
+0.91 (3.11%)
Nov 9, 2026, 11:25 AM EST - Market open

Agios Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
128.5589.1376.2588.21139.26203.13
Short-Term Investments
501.46765.3817.46688.72643.86816.89
Cash & Short-Term Investments
630.01854.43893.71776.93783.121,020
Cash Growth
-33.88%-4.40%15.03%-0.79%-23.23%78.04%
Accounts Receivable
32.910.584.112.812.21-
Other Receivables
-0.2-1.10.37.28
Receivables
32.910.784.113.912.517.28
Inventory
37.8432.9227.6219.088.49-
Prepaid Expenses
51.3543.9340.1733.9238.6636.94
Total Current Assets
752.1942.05965.6833.84832.771,064
Property, Plant & Equipment
30.8541.2354.5569.7988.12104.23
Long-Term Investments
277.01310.01638.3229.44313.87266.38
Other Long-Term Assets
4.083.934.724.063.962.9
Total Assets
1,0641,2971,663937.121,2391,438

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
19.9318.3616.649.7818.6216.7
Accrued Expenses
38.0145.4646.8643.1730.3531.97
Current Portion of Leases
19.6518.3916.7815.0113.6611.16
Current Income Taxes Payable
--0.87---
Total Current Liabilities
77.5982.2181.1667.9662.6359.83
Long-Term Leases
6.8821.8240.2156.997285.94
Other Long-Term Liabilities
0.240.090.881.163.28-
Total Liabilities
84.7104.11122.24126.1137.9145.76

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.070.070.070.07
Additional Paid-In Capital
2,6132,5552,4942,4372,3862,334
Retained Earnings
-826.56-561.71-148.92-822.65-470.56-238.76
Treasury Stock
-802.49-802.49-802.49-802.49-802.49-802.49
Comprehensive Income & Other
-4.292.19-1.52-0.44-12.54-1.2
Shareholders' Equity
979.341,1931,541811.021,1011,292
Total Liabilities & Equity
1,0641,2971,663937.121,2391,438

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
26.5340.2156.997285.6697.09
Net Cash (Debt)
880.491,1241,475734.371,0111,189
Net Cash Growth
-27.39%-23.78%100.86%-27.39%-14.96%110.37%
Net Cash Per Share
14.9019.3925.4813.2018.4619.67
Filing Date Shares Outstanding
59.8158.5957.356.1955.2954.64
Total Common Shares Outstanding
59.7858.4557.1655.9555.0454.33
Working Capital
674.51859.85884.44765.88770.141,004
Book Value Per Share
16.3820.4126.9614.5020.0023.78
Tangible Book Value
979.341,1931,541811.021,1011,292
Tangible Book Value Per Share
16.3820.4126.9614.5020.0023.78
Machinery
-30.6229.7629.7335.1233.8
Construction In Progress
-2.750.90.610.667.37
Leasehold Improvements
-37.5237.5237.2837.2832.73
SEC Filings: 10-K · 10-Q